APP and Cognitive impairment: Also, it is reported that the synthetic formula of AXT’ docosahexaenoic-acid-acylated AXT diesters (AXT-DHA) ameliorated cognitive disorders in mice with amyloid protein precursor/presenilin-1 (APP/PSEN1) by reducing chronic neuroinflammation and oxidative stress [61].